1. Home
  2. RLYB vs MLGO Comparison

RLYB vs MLGO Comparison

Compare RLYB & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • MLGO
  • Stock Information
  • Founded
  • RLYB 2018
  • MLGO 2018
  • Country
  • RLYB United States
  • MLGO China
  • Employees
  • RLYB N/A
  • MLGO 87
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • MLGO EDP Services
  • Sector
  • RLYB Health Care
  • MLGO Technology
  • Exchange
  • RLYB Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • RLYB 24.1M
  • MLGO 104.2M
  • IPO Year
  • RLYB 2021
  • MLGO N/A
  • Fundamental
  • Price
  • RLYB $0.51
  • MLGO $10.46
  • Analyst Decision
  • RLYB Hold
  • MLGO
  • Analyst Count
  • RLYB 2
  • MLGO 0
  • Target Price
  • RLYB N/A
  • MLGO N/A
  • AVG Volume (30 Days)
  • RLYB 336.7K
  • MLGO 705.5K
  • Earning Date
  • RLYB 11-06-2025
  • MLGO 12-16-2025
  • Dividend Yield
  • RLYB N/A
  • MLGO N/A
  • EPS Growth
  • RLYB N/A
  • MLGO N/A
  • EPS
  • RLYB N/A
  • MLGO 4.04
  • Revenue
  • RLYB $761,000.00
  • MLGO $61,302,336.00
  • Revenue This Year
  • RLYB N/A
  • MLGO N/A
  • Revenue Next Year
  • RLYB N/A
  • MLGO N/A
  • P/E Ratio
  • RLYB N/A
  • MLGO $2.35
  • Revenue Growth
  • RLYB 154.51
  • MLGO N/A
  • 52 Week Low
  • RLYB $0.22
  • MLGO $7.82
  • 52 Week High
  • RLYB $1.24
  • MLGO $972.00
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 45.16
  • MLGO 52.61
  • Support Level
  • RLYB $0.48
  • MLGO $9.50
  • Resistance Level
  • RLYB $0.60
  • MLGO $11.47
  • Average True Range (ATR)
  • RLYB 0.04
  • MLGO 0.77
  • MACD
  • RLYB -0.01
  • MLGO -0.08
  • Stochastic Oscillator
  • RLYB 33.67
  • MLGO 51.01

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: